Active ingredient
Pazopanib
9 finished FDA listings contain Pazopanib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PAZOPANIB, PAZOPANIB HYDROCHLORIDE
- Dosage forms
- Tablet, Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 9
- Strengths listed
- 200 mg/1 · 400 mg/1
- Brand names in FDA listings
- Pazopanib, Votrient
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 714438
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 022465 | NOVARTIS | 2009-10-19 | 1 |
| ANDA 217517 | TEVA PHARMS INC | 2023-10-19 | 2 |
| ANDA 217713 | APOTEX | 2023-10-19 | 2 |
| ANDA 215837 | SUN PHARM | 2023-10-19 | 1 |
| ANDA 218231 | NOVUGEN | 2024-04-23 | 1 |
| ANDA 219034 | EUGIA PHARMA | 2024-12-04 | 1 |
| ANDA 219922 | TORRENT | 2025-09-04 | 1 |
Official labeling on DailyMed
- PAZOPANIB TABLET, FILM COATED [SUN PHARMACEUTICAL INDUSTRIES, INC.] · version 4 · 2026-05-28
- PAZOPANIB (PAZOPANIB HYDROCHLORIDE) TABLET, FILM COATED [TORRENT PHARMACEUTICALS LIMITED] · version 3 · 2026-05-13
- PAZOPANIB TABLET, FILM COATED [AVKARE] · version 2 · 2026-01-21
- VOTRIENT (PAZOPANIB HYDROCHLORIDE) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] · version 15 · 2025-12-17
- PAZOPANIB TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] · version 3 · 2025-12-08
- PAZOPANIB TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] · version 1 · 2024-12-09
- PAZOPANIB (PAZOPANIB HYDROCHLORIDE) TABLET, FILM COATED [NOVUGEN PHARMA (USA) LLC.] · version 2 · 2024-08-20
- PAZOPANIB TABLET, FILM COATED [TEVA PHARMACEUTICALS, INC.] · version 3 · 2024-06-03
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.